41
Views
54
CrossRef citations to date
0
Altmetric
Research Article

Prognostic Significance of Microvessel Density and Vascular Endothelial Growth Factor (VEGF) Expression in non-Hodgkin's Lymphoma

, , , &
Pages 2089-2093 | Published online: 05 Aug 2011

References

  • Ellis, L.M. and Fidler, I.J. (1996) "Angiogenesis and metastasis", Fur J. Cancer 32A(14), 2413–2422.
  • Fidler, I.J., Kumar, R., Bilenberg, D.R. and Ellis, L.K. (1998) "Molecular determinants of angiogenesis in cancer metastasis. Molecular determinants of angiogenesis in cancer metastasis", Cancer.!. Sci. Am., Suppl., 58–66.
  • Folkman, J. (1995) "Clinical applications of angiogenesis", N. EngL J. Med. 333(26), 1757–1763.
  • Neufeld, G., Cohen, T., Gengrinovitch, S. and Poltrak, Z. (1999) "Vascular endothelial growth factor (VEGF) and its receptors", EASES J. 13, 9–22.
  • Mattem, J., Koomagi, R. and Volm, M. (1996) "Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumor cell proliferation in human epidermoid carcinoma", BE J. Cancer 73, 931–934.
  • Olson, T.A., Mobanraj, D., Carson, L.F. and Ramorkrishnon, S. (1994) "Vascular permeability factor gene expression in normal and neoplastic human ovaries", Cancer Res. 54, 276–280.
  • Salven, P., Heilddla, P. and Joensuu, H. (1997) "Enhnced expression of endothelial growth factor in metastatic melanoma", Br J. Cancer 76(7), 930–934.
  • Shibusa, T., Shijuba, N. and Abe, S. (1998) "Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma", Clin. Cancer Res. 4, 1483–1487.
  • Takahashi, Y., Tucher, S.L., Kitadai, Y., et al. (1997) "Vessel counts and expression of vascular endothelial growth factor as prognostic factor in node-negative colon cancer", Arch. Surg. 132, 541–546.
  • Toi, M., Taniguchi, T., Yamamoto, Y., et al. (1998) "Clinical significance of the determination of angiogenic factors", Br J. Cancer 77(6), 998–1002.
  • The Non-Hodgkin's Lymphoma Pathologic Classification Project ( 1982) "National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage", Cancer 49, 2112–2135.
  • Shipp, M.A., Harrington, D.L. and Anderson, J. (1993) "Develop-ment of practice model for aggressive lymphoma", N. Engl, J. Med. 329, 987–994.
  • Cheson,Horning, SJ., Coiffier, B., etal, (1999) "Report of anInternational Workshop to standardize response criteria for non-Hodgkin's lymphomas", ./. Clin. OncoL 17, 1244–1253.
  • Eppenberger, U., Kueng, W., Schlaeppi, J.M., et al. (1998) "Markers of tumor angiogenesis and proteolysis independently. Define high and low-risk subjects of node-negative breast cancer", .1. Clin. Onco1 16, 3129–3136.
  • Harok, E.R., Leek, R., Klenlc, N., et al. (1992) "Angiogenesis, assessed by platelet/endothelial cell adhesion molecular antibodies, as indicator of a node metastases and survival in breast cancer", Lancet 340, 1220–1224.
  • Linderholm, B., Towelin, B., Grankerist, K. and Henriksson, R. (1998) "Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma",). Clin. OncoL 16, 3121–3128.
  • Wainer, N., Sample, J.P., Welch, W.R. and Follcman, J. (1991) "Tumor angiogenesis and metastasis correlation in invasive breast carcinoma", N. Engl. J. Med. 324, 1–8.
  • Macchiarini, P., Fortanini, G., Hardin, M.J., etal. (1992) "Relation of neovascularisation to metastasis of non-small cell lung cancer", Lancet 340, 145–146.
  • Panzella, F., Bacco, A.D., Andreola, S., etal. (1996) "Angiogenesis in primary lung cancer and lung secondaries", Eur J. Cancer 32A(14), 2494–2500.
  • Yamazaki, K., Abe, S., Takekoma, H., et al. (1994) "Tumor angiogenesis in lung adenocarcinoma", Cancer 74, 2245–2250.
  • Sato, F., Shimad, T., Wetanebe, G., et al. (1999) "Expression of vascular endothelial growth factor, matrix metallo proteinase-9 and E-cadherin in the process of lymph node metastasis in oesophageal cancer", Br J. Cancer 80(9), 1366–1372.
  • Takano, S., Yoshii, Y., Kondo, S., et al. (1996) "Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients", Cancer Res. 56, 2185–2190.
  • Graham, C.H., Rivers, J., Kerbel, R.S., et aL (1994) "Extend of vascularization as a prognostic indicator in thin (76 mm) malign melanoma", Am. J. PathoL 145(3), 510–514.
  • Fulcuda, S., Shrahama, T., Imazono, Y., etal. (1999) "Expression of vascular endothelial growth factor in patients with testicular germ cell tumors as an indicator of metastatic disease", Cancer 85, 1323–1330.
  • Chung, Y.S., Maeda, K. and Sowa, M. (1996) "Prognostic value of angiogenesis in gastrointestinal tumors", Eur J. Cancer 14(32A), 2501–2505.
  • Saito, H., Tsusitoni, S., Ikeguchi, M., et al. (1998) "Relationship between the expression of vascular endothelial growth factor and the density of dentritic cells in gastric adenocarcinoma", Br J. Cancer 78(12), 1573–1577.
  • Olson, T.A., Mobanraj, D., Carson, L.F. and Ramorkrishnon, S. (1994) "Vascular permeability factor gene expression in normal and neoplastic human ovaries", Cancer Res. 54, 276–280.
  • Ogawa, S., Kaku, T., Kobayashi, H., et al. (2002) "Prognostic significance of microvessel density, vascular cuffing and vascular endothelial growth factor expression in ovarian carcinoma: a special review for clear cell adenocarcinoma", Cancer Lett. 176(1), I 1 I —118.
  • Ribatti, D., Vacca, A., Quondamateo, F., et al. (1999) "Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma", Br. J. Cancer 79(3/4), 451–455.
  • Vacca, A., Ribatti, D., Rancall, L., et al. (1994) "Bone marrow angiogenesis and progression in multiple myeloma", Br. J. HaematoL 87, 503–506.
  • Rajkumar, S.V. and Kyle, R.A. (2001) "Angiogenesis in multiple myeloma", Semin. OncoL 28(6), 560–564.
  • Paydas, S., Zorludemir, S., Baslamisli, F. and Tuncer, I. (2002) "Vascular endothelial growth factor(VEGF) expression in plasma-cytoma", Leuk. Lymphoma 43(1), 139–143.
  • Pruneri, G., Bertolini, F., Soligo, D., etal. (1999) "Angiogenesis in myelodysplastic syndromes", Br J. Cancer 81(8), 1398–1401.
  • Korkolopoulo, P., Apostolidou, E., Pavlopoulos, P.M., etal. (2001) "Prognostic evaluation of the microvascular network in myelo-dysplastic syndromes", Leukemia 15(9), 1369–1376.
  • Bairey, 0., Zimra, Y., Kaganovsky, E., Shalclai, M., et al. (2000) "Microvessel density in chemosensitive and chemoresistant diffuse large B-cell lymphoma", Med. OncoL 17(4), 314–318.
  • Ribatti, D., Vacca, A., Marzullo, A., etal. (2000) "Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas", hit. J. Cancer 85(2), 171–175.
  • Ribatti, D., Vacca, A., Nico, B., et al. (1996) "Angiogenesis spectrum in the stoma of B-cell non-Hodgkin's lymphomas. An immunohistochemical and ultrastructural study", Eur. J. HaematoL 56(1-2), 45–53.
  • Vacca, A., Ribatti, D., Fanelli, M., et al. (1996) "Expression of tenascin is related to histologic malignancy and angiogenesis in B-cell non-Hodgkin's lymphomas", Leak. Lymphoma 22(5-6), 473–481.
  • List, A.F. (2001) "Vascular endothelial growth factor signaling pathway as an emerging target in hematologic malignancies", Oncologist 6\(Suppl. 5), 24–31.
  • Foss, H.D., Aravjo, I., Demel, G., et al. (1997) "Expression of vascular endothelial growth factor in lymphomas and Castleman disease", J. Pathill. 183, 44–50.
  • Aoki, Y. and Tosato, G. (2001) "Vascular endothelial growth factor/vascular permeability factor in the pathogenesis of primary effusion lymphomas", Leak. Lymphoma 41(3-4), 229–237.
  • Bertolini, F., Paolucci, M„ Peccetori, F. et al. (1999) "Angiogenic growth factors in non-Hodgkin's lymphoma." 4th. Congress of the European Haematology Association (EHA), June 9–12, Barcelona, Spain. Abstract 55–0508.
  • Potti, A., Ganti, A.K., Kargas, S. and Koch, M. (2002) "Iinmunhistochemical detection of c kit(CDI17) and vascular endothelial growth factor (VEGF) overexpression in mantle cell lymphoma", Anticancer Res. 22(5), 2899–2901.
  • Niitsu, N., Okamato, M., Nakamine, H., etal. (2002) "Simultaneous elevation of serum concentrations of vascular endothelial growth factor and interleukin-6 as independent predictors of in aggressive non-Hodgkin's lymphoma", Eur. J. Haenultol. 68(2), 91–100.
  • Hayashibra, T., Yamada, Y., Onimura, Y., et al. (2002) "Matrix metalloproteinase-9 and vascular endothelial growth factor: a possible link in adult T-cell leukemia cell invasion", Br. J. Haematol. 116( I ), 94–102.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.